AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglanz-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Sporodik Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaglanz-M 500 Tablet

Glucoduo-500 is a dual-action medication managing elevated blood glucose in type 2 diabetes patients. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Glucoduo-500 might be prescribed independently or alongside other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and existing medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical guidance. Adherence to your doctor's dietary and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential risk, especially when combined with insulin or sulfonylureas; learn hypoglycemia recognition and management. This medication isn't universally suitable. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or lactating individuals should seek medical advice prior to use. Interaction with other medications is possible; disclose all medications to your doctor for safety. Alcohol should be minimized due to its potential to decrease blood glucose. Your physician will monitor your kidney function and blood sugar throughout treatment.

Uses of Sitaglanz-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Sitaglanz-M 500 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; do not fracture, pulverize, or chew it. Administer Sitaglanz-M 500 Tablet with a meal.

Common Side effects of Sitaglanz-M 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglanz-M 500 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitaglanz-M 500 Tablet with a meal.

How Sitaglanz-M 500 Tablet works:

Sitaglanz-M 500 Tablet combines sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglanz-M 500 Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaglanz-M 500 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaglanz-M 500 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglanz-M 500 Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For individuals with severe kidney disease, Sitaglanz-M 500 Tablet use is contraindicated. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disorders should likely refrain from using Sitaglanz-M 500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaglanz-M 500 Tablet :

Should you forget a dose of Sitaglanz-M 500 Tablet, take it immediately if you remember. If, however, your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Never take a double dose.

Facts to Know About Sitaglanz-M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaglanz-M 500 Tablet

Sitaglanz-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitaglanz-M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Sitaglanz-M 500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaglanz-M 500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglanz-M 500 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitaglanz-M 500 Tablet) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-associated lactic acidosis, or MALA). This rare side effect is why it's avoided in patients with kidney problems, the elderly, or those who drink heavily. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Sitaglanz-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaglanz-M 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Sitaglanz-M 500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglanz-M 500 Tablet and alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (like Sitaglanz-M 500 Tablet) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitaglanz-M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglanz-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaglanz-M 500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaglanz-M 500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglanz-M 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitaglanz-M 500 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaglanz-M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitaglanz-M 500 Tablet
151
MRP 175
13% off